CATXのROE（自己資本利益率）は？

Perspective Therapeutics Inc.のROEは-31.99%です。

CATXの配当利回りは？

Perspective Therapeutics Inc.の配当利回りは0.00%です。

CATXの品質スコア（Quality Score）は？

当社のAIはCATXの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

CATXは今が買い時ですか？

当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

CATXはどのセクターに属しますか？

Perspective Therapeutics Inc.はHealthcare >> Medical Devicesセクターに分類されます（NYSE MKT市場）

CATX (NYSE MKT) 株価分析 | PERSPECTIVE THERAPEUTICS INC.

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-04 | FS: 2026-03-31)

CATX AI Analysis Summary

Our AI summary for CATX: Perspective Therapeutics Inc. (NYSE MKT), Healthcare >> Medical Devices sector. The stock currently trades at ROE of -31.99%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

CATX

Perspective Therapeutics Inc.

US:NYSE MKT STOCK Healthcare >> Medical Devices

USD 3.00

-0.01 (-0.33%) Day Change

Watchlist Portfolio Compare Chart

0.01

D/E

-32.0%

ROE

-27.1%

ROA

0.00%

Div Yield

PERSPECTIVE THERAPEUTICS INC.
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 3.00 Price -0.01 (-0.33%) Day Change	NEWS SCORE: N/A

CATX, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	N/A
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.00
PBV / Sector	0.99 / -104.79 GREAT
Earning Per Share	-0.97

PE / Sector	N/A / 32.46
PEG or PE/Growth / Sector	N/A / 0.47
Average 1M Daily Value	4.43 M GREAT
Average 1W Daily Value	3.03 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

52%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-17,982.69 / 20.45
NPM Average (%) / Sector	-7,710.03 / -15.38
NPM Change Average (%) / Sector	426.69 / 7.18 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-27.05 / 33.84
ROA Average (%) / Sector	-32.34 / 4.52
ROA Change Average (%) / Sector	18.32 / 84.54 GOOD
ROE (%) / Sector	-31.99 / -171.76
ROE Average (%) / Sector	-39.56 / -17.99
ROE Change Average (%) / Sector	30.34 / -511.28 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.44
Dividend Average (%) / Sector	N/A / 1.85
Dividend Change Average (%) / Sector	N/A / 2.57

登録情報

Analyze Date	2026-08-05 07:59:57
Symbol	CATX
Name	PERSPECTIVE THERAPEUTICS INC.
Sector	Healthcare >> Medical Devices
Market	NYSE MKT
Listed Shares	114.05 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	343.28 / 20,480.80

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 2401 Elliott Avenue, Seattle, WA, United States, 98121

Phone: 206 676 0900

Website: https://www.perspectivetherapeutics.com

Employees: 163

Sector: Healthcare >> Medical Devices

Description: Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a beta emitting therapy; VMT01, which is in Phase 1/2a clinical trials for second-line or later treatment of patients with progressive melanocortin 1 receptor (MC1R) positive metastatic melanoma; and PSV359, a targeted alpha therapy targeting fibroblast activation protein alpha. The company also develops Pluvicto, a betaemitting radioligand therapy to treat progressive prostate-specific membrane antigen (PSMA) positive metastatic castration-resistant prostate cancer. It has a clinical trial collaboration agreement with Bristol Myers Squibb to evaluate the safety and tolerability of [212Pb] VMT01 in combination with nivolumab in patients with histologically confirmed melanoma and positive MC1R imaging scans. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 2004 and is headquartered in Seattle, Washington.